Ribosomal protein L21 pseudogene 99 (RPL21P99)

RPL21P99 is a processed pseudogene belonging to the family of RPL21 pseudogenes, which are fragments or copies of the ribosomal protein L21 gene sequence inserted into the genome through retrotransposition[2]. These pseudogenes, including RPL21P99, lack the capacity to encode a functional protein due to interruptions (frameshifts, stop codons, or truncations) in their sequences[2]. Their presence in the genome is a result of random integration events and not biological selection. The parent gene, RPL21, encodes a structural component of the 60S ribosomal subunit involved in protein synthesis; however, pseudogenes such as RPL21P99 do not participate in these or any known cellular functions. Most ribosomal protein pseudogenes have no known function or clinical significance, and there are no drugs, biomarker roles, or disease associations documented for RPL21P99 in the literature[2][4][7]. There is no evidence supporting RPL21P99 as a therapeutic target or biomarker. Explanation of inaccuracies: - RPL21P99 is a pseudogene and not a functional gene or protein, and pseudogenes are not considered druggable targets in therapeutic research or clinical practice[2][4]. - Search results confirm its nature as a pseudogene, with no indication of involvement in disease, drug interaction, or biomarker utility[2][6]. If you are seeking information about a functional ribosomal protein, the correct entry would be "Ribosomal protein L21" (abbreviated RPL21)[1][4][7].

Other names

RPL21_41_1222RPL21P99